Key Analyst Joins Leading U.S. Cannabis Company


Ryan Allway

May 24th, 2018

News, Top News


Los Angeles (May 24, 2018) – MedMen Enterprises has hired Vahan Ajamian, one of the leading financial analysts in the emerging cannabis industry, as its new managing director of analyst relations.
Named one of the “rising stars in the marijuana investment scene” by Business Insider, Ajamian has more than a decade of experience in equity research and analysis. A capital market forerunner in the cannabis sector, he was one of the first to cover Canada’s growing list of publicly traded cannabis companies and is an expert on the U.S. sector.
Cannabis is the fastest growing industry in North America. It had sales of $9.2 billion in 2017 and is expected to grow to $47.3 billion by 2027, according to BDS Analytics. As the industry matures, cannabis companies have increasingly sought to raise capital via the public markets. The more established companies have listed on bona fide exchanges in Canada and the U.S. like the New York Stock Exchange, the Nasdaq, the Toronto Stock Exchange and the Canadian Securities Exchange. Ajamian will be MedMen’s principal liaison with brokers and financial analysts covering investment opportunities in the cannabis space.
“The cannabis industry needs professional expertise at all levels and MedMen has been assembling the best talent in every field,” said MedMen CEO Adam Bierman. “Vahan is a respected voice of authority in the cannabis sector, and we are proud to have him represent MedMen.”
Prior to joining MedMen, Ajamian was an equity research analyst at Beacon Securities, a full-service independent investment firm with offices across Canada. He was the first analyst to report on the broader U.S. cannabis sector and was frequently cited by both investors and news media publications. Prior to Beacon Securities, Ajamian was an equity research associate at TD Securities.

“Cannabis is an exciting, fast moving space and MedMen is leading the charge,” Ajamian said. “I am proud to be joining a company that is defining the industry.”

About MedMen:
MedMen Enterprises is the preeminent cannabis company in the U.S. and the most recognized brand in the emerging marijuana industry, with assets and operations in key markets. Based in Los Angeles, MedMen employs more than 800 employees, and is the single largest financial supporter of progressive marijuana laws. Visit http://www.medmen.com.
Media Contact:
Briana Chester
1-424-465-4419

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading